drugset / Trial / NCT04196855

Summary

Investigation into the use of teriparatide in the treatment of stress fractures. Primary outcome is healing on MRI, secondary outcomes are pain, time spent in rehabilitation and future stress fractures. This study will help the investigators understand how to treat stress fractures in the future.

Timeline

Start
2019-12-23
Primary completion
2022-06
Completion
2022-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Teriparatide Protein / enzyme biologic 20 ug

Indications

No indication recorded.